Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Louise Koepke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Kidney International|July 15, 2005
Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688Oliver Gross, Marie-Louise Koepke, Bogdan Beirowski, et al.
Kidney International|August 1, 2009
The case: the eyes have it!Ralph Kettritz, Saban Elitok, Marie-Louise Koepke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2007
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndromeMarie-Louise Koepke, Manfred Weber, Eckhard Schulze-Lohoff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 7, 2004
Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosisOliver Gross, Eckhard Schulze-Lohoff, Marie-Louise Koepke, et al.
Kidney International|March 13, 2003
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndromeOliver Gross, Bogdan Beirowski, Marie-Louise Koepke, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Kidney International|July 15, 2005
Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688Oliver Gross, Marie-Louise Koepke, Bogdan Beirowski, et al.
Kidney International|August 1, 2009
The case: the eyes have it!Ralph Kettritz, Saban Elitok, Marie-Louise Koepke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2007
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndromeMarie-Louise Koepke, Manfred Weber, Eckhard Schulze-Lohoff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 7, 2004
Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosisOliver Gross, Eckhard Schulze-Lohoff, Marie-Louise Koepke, et al.
Kidney International|March 13, 2003
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndromeOliver Gross, Bogdan Beirowski, Marie-Louise Koepke, et al.
Pageof 1